ZIMMER BIOMET HOLDINGS, INC.

ZBHSEC EDGAR

Orthopedic, Prosthetic & Surgical Appliances & Supplies(DE)CIK: 1136869

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue from Contract with Customer, Excluding Assessed Tax	$7.4B	$6.9B	$6.8B	$6.1B	$8.0B
Cost of Goods and Services Sold	$2.1B	$2.0B	$2.0B	$1.8B	$2.3B
Gross Profit	—	—	—	—	—
Research and Development Expense	—	—	—	—	—
Selling, General and Administrative Expense	$2.8B	$2.8B	$2.8B	$2.7B	$3.3B
Operating Expenses	—	—	—	—	—
Operating Income (Loss)	$1.3B	$696.3M	$860.3M	$83.1M	$1.1B

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Assets	$21.4B	$21.5B	$21.1B	$23.5B	$24.4B
Assets, Current	$4.7B	$4.6B	$4.4B	$4.9B	$5.1B
Cash and Cash Equivalents, at Carrying Value	$525.5M	$415.8M	$375.7M	$378.1M	$802.1M
Accounts Receivable, after Allowance for Credit Loss, Current	$1.5B	$1.4B	$1.4B	$1.3B	$1.5B
Inventory, Net	$2.2B	$2.4B	$2.1B	$2.1B	$2.5B
Liabilities	$8.9B	$9.0B	$9.0B	$10.8B	$12.2B
Liabilities, Current	$2.5B	$2.9B	$2.4B	$3.5B

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Net Cash Provided by (Used in) Operating Activities	$1.6B	—	—	—	$1.6B
Net Cash Provided by (Used in) Investing Activities	-$778.9M	—	—	—	-$729.3M
Net Cash Provided by (Used in) Financing Activities	-$763.5M	—	—	—	-$779.9M
Payments to Acquire Property, Plant, and Equipment	$291.1M	$187.9M	$143.6M	$111.9M	$207.1M
Payments of Ordinary Dividends, Common Stock	$200.9M	$201.2M	$200.1M	$198.5M	$196.7M
Payments for Repurchase of Common Stock	$692.2M	$126.4M	$126.4M	$126.4M	—

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)